SEC 13F Intelligence

Managers / Q3 2024 · view latest →

HighVista Strategies LLC

CIK 0001335325 · 200 CLARENDON STREET, 50TH FLOOR, BOSTON, MA, 02116 · 617-406-6500

Reported Value
$290M
Q3 2024
Positions
142
Filings on Record
30
2019–present window
Filed
Nov 14, 2024
original filing

Summary

Highvista Strategies LLC reported $290M in U.S.-listed holdings across 142 positions for Q3 2024.

Its largest position, DBC, represents 11.0% of the portfolio.

Compared with Q2 2024, the fund opened 37 new positions and exited 32.

Portfolio Metrics

Turnover
+23.4%
vs prior filed quarter
Top-10 Concentration
+25.5%
share of reported value
Largest Position
+11.0%
Invesco Db Commdy Indx Trck
New / Exited
37 / 32
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $116MQ4 ’18Q1 ’19: $123MQ2 ’19: $195MQ3 ’19: $147MQ4 ’19: $132MQ4 ’19Q1 ’20: $108MQ2 ’20: $121MQ3 ’20: $137MQ4 ’20: $157MQ4 ’20Q1 ’21: $135MQ2 ’21: $141MQ3 ’21: $151MQ4 ’21: $126MQ4 ’21Q1 ’22: $157MQ2 ’22: $166MQ3 ’22: $175MQ4 ’22: $168MQ4 ’22Q1 ’23: $123MQ2 ’23: $219MQ3 ’23: $216MQ4 ’23: $276MQ4 ’23Q1 ’24: $280MQ2 ’24: $274MQ3 ’24: $290MQ4 ’24: $269MQ4 ’24Q1 ’25: $260MQ2 ’25: $272MQ3 ’25: $408MQ4 ’25: $388MQ4 ’25Q1 ’26: $362Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 70.9%ETP: 11.6%ADR: 9.9%Other: 7.6%
  • Common Stock · 70.9% · $206M
  • ETP · 11.6% · $34M
  • ADR · 9.9% · $29M
  • Other · 7.6% · $22M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
GEVGE VERNOVA INCNEW+14.7K14.7K+$4M$4M
AMGNAMGEN INCNEW+10.1K10.1K+$3M$3M
EWTXEDGEWISE THERAPEUTICS INCNEW+88.8K88.8K+$2M$2M
DYNDYNE THERAPEUTICS INCNEW+65.5K65.5K+$2M$2M
ADSKAUTODESK INCNEW+7.5K7.5K+$2M$2M
LADLITHIA MTRS INCNEW+6.0K6.0K+$2M$2M
DALDELTA AIR LINES INC DELNEW+37.2K37.2K+$2M$2M
HPEHEWLETT PACKARD ENTERPRISE CNEW+88.9K88.9K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2024

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1DBCINVESCO DB COMMDY INDX TRCKhistory →UNIT11.03%$32M1.44M
2AMZNAMAZON COM INChistory →COM2.07%$6M32.2K
3PCVXVAXCYTE INChistory →COM1.76%$5M44.7K
4ACLXGBXARCELLX INChistory →COMMON STOCK1.59%$5M55.1K
5CTLTEURCATALENT INChistory →COM1.58%$5M75.6K
6CRMSALESFORCE INChistory →COM1.57%$5M16.6K
7JNPJUNIPER NETWORKS INChistory →COM1.54%$4M114.7K
8HCP2EURHASHICORP INChistory →COM CL A1.52%$4M130.2K
9VRDNVIRIDIAN THERAPEUTICS INChistory →COM1.45%$4M185.2K
10AKXANSYS INChistory →COM1.41%$4M12.8K
11XPOXPO INChistory →COM1.40%$4M37.7K
12PTGXPROTAGONIST THERAPEUTICS INChistory →COM1.39%$4M89.5K
13HESHESS CORPhistory →COM1.35%$4M28.9K
14ARGXARGENX SEhistory →SPONSORED ADR1.34%$4M7.2K
15AMEDAMEDISYS INChistory →COM1.31%$4M39.3K
16GEVGE VERNOVA INChistory →COM1.29%$4M14.7K
17AXSMAXSOME THERAPEUTICS INChistory →COM1.29%$4M41.5K
18MERUS N VCOM1.27%$4M74.0K
19APGEAPOGEE THERAPEUTICS INChistory →COM1.25%$4M61.8K
20ACIALBERTSONS COS INChistory →COMMON STOCK1.20%$3M188.8K
21IM8NINSMED INChistory →COM PAR $.011.14%$3M45.4K
22CAPRI HOLDINGS LIMITEDSHS1.14%$3M77.7K
23AMGNAMGEN INChistory →COM1.12%$3M10.1K
24CARTMAPLEBEAR INChistory →COM1.10%$3M78.5K
25BCYCBICYCLE THERAPEUTICS PLChistory →SPONSORED ADS1.09%$3M139.5K
26MSFTMICROSOFT CORPhistory →COM1.08%$3M7.3K
27SYRESPYRE THERAPEUTICS INChistory →COM NEW1.07%$3M105.4K
28X0M1XOMA ROYALTY CORPORATIONhistory →COM NEW1.05%$3M114.5K
29KROSKEROS THERAPEUTICS INChistory →COM1.04%$3M52.1K
30NUVLNUVALENT INChistory →COM1.02%$3M29.0K
31XENEXENON PHARMACEUTICALS INChistory →COM1.00%$3M73.8K
32ELVNENLIVEN THERAPEUTICS INCCOM0.99%$3M112.5K
33OLMAOLEMA PHARMACEUTICALS INCCOM0.87%$3M212.2K
34RVMDREVOLUTION MEDICINES INCCOM0.87%$3M55.6K
35COGTCOGENT BIOSCIENCES INCCOM0.84%$2M225.6K
36EWTXEDGEWISE THERAPEUTICS INCCOM0.82%$2M88.8K
37DYNDYNE THERAPEUTICS INCCOM0.81%$2M65.5K
38PFSIPENNYMAC FINL SVCS INC NEWCOM0.76%$2M19.3K
39MLTXMOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD0.76%$2M43.5K
40BABAALIBABA GROUP HLDG LTDSPONSORED ADS0.75%$2M20.4K
41GOOGALPHABET INCCAP STK CL C0.72%$2M12.5K
42ADSKAUTODESK INCCOM0.71%$2M7.5K
43TVTXTRAVERE THERAPEUTICS INCCOM0.71%$2M147.2K
44PTCPTC INCCOM0.70%$2M11.2K
45LAURLAUREATE EDUCATION INCCOMMON STOCK0.70%$2M121.6K
46RYTMRHYTHM PHARMACEUTICALS INCCOM0.68%$2M37.4K
47AUTLAUTOLUS THERAPEUTICS PLCSPON ADS0.67%$2M533.0K
4837MMRC GLOBAL INCCOM0.66%$2M149.8K
49LADLITHIA MTRS INCCOM0.66%$2M6.0K
50DALDELTA AIR LINES INC DELCOM NEW0.65%$2M37.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$362M156May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$388M145Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$408M148Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$272M146Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$260M148May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$269M137Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$290M142Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$274M138Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$280M131May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$276M126Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$216M132Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$219M134Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$123M108May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$168M105Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$175M113Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$166M110Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$157M86May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$126M69Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$151M127Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$141M116Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$135M125May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$157M117Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$137M113Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$121M100Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$108M65May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$132M119Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$147M126Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$195M108Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$123M112May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$116M113Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • HighVista Private Capital Management LLC

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.